SCHEMBL4904153

SCHEMBL4904153

CCOC(=O)Cc1csc(-c2ccc(F)cc2F)n1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
HTT P42858 2/20 0.51
LMNA P02545 4/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.46
MAPK1 P28482 1/20 0.46
GAA P10253 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TSHR P16473 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907597 0.84 LMNA (0.67) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL14098711 0.81 PTGER1 (0.52) MAPTMEN1KMT2ACYP3A4CYP2C9
SCHEMBL5717729 0.81 LMNA (0.51) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL24240025 0.80 CYP19A1 (0.48) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL30350121 0.80 CYP19A1 (0.55) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL24240005 0.80 CYP19A1 (0.55) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL30350001 0.80 CYP19A1 (0.48) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL3103929 0.80 MAPT (0.56) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL4900722 0.79 MAPT (0.53) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL15014149 0.79 MAPT (0.45) MAPTNPC1RAB9ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MAPT 1858/4885NPC1 50/4885RAB9A 2581/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MAPT 1786/4885NPC1 59/4885RAB9A 2271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MAPT 1786/4885NPC1 59/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.